1. From the Berman-Gund Laboratory for the Study of Retinal Degenerations, Harvard Medical School, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts; the
2. Division of Molecular Therapy, Institute of Ophthalmology, University College London, London, United Kingdom.